微创玻璃体切除术摘除前部葡萄膜肿瘤的疗效

Efficacy of minimally invasive incision vitrectomy for extirpation of anterior uveal tumor

目的评价经23G微创玻璃体切除术摘除前部葡萄膜肿瘤的效果。方法对2014年6月至2016年7月经23G微创玻璃体切除术摘除前部葡萄膜肿瘤4例(4眼)的临床资料进行回顾性研究。结果其中睫状体肿瘤2例,睫状体脉络膜肿瘤2例。组织病理学检查:2例睫状体无色素上皮腺瘤,1例神经鞘瘤,1例神经纤维瘤。随访6~18个月,所有患者术后最佳矫正视力均较术前明显提高(P<0.05),且无肿瘤复发。结论经23G微创玻璃体切除术摘除前部葡萄膜肿瘤不仅创伤小,手术并发症少,而且能有效改善视力,并可对摘除的肿瘤组织进行病理学检查,是一种安全有效的手术方式。

Objective To evaluate the efficacy of 23 G minimally invasive incision vitrectomy for extirpation of anterior uveal tumor. Methods The data of 4 eyes of 4 patients with anterior uveal tumor from Jun. 2014 to Jul. 2016 were analyzed retrospectively. The tumor were extirpated with 23 G minimally invasive vitrectomy. Results There were 2 cases with ciliary body tumors and 2 cases with ciliary choroidal tumors. Histopathological examination:2 cases of adenoma of the non-pigmented ciliary epithelium, 1 case of schwannomas and 1 case of neurofibroma. After 6 to 18 months of follow-up, the best corrected visual acuity (BCVA) of all patients was significantly better than that before surgery(P<0. 05), and there was no tumor recurrence. Conclusion The extirpation of anterior uveal tumor with 23 G minimally invasive vitrectomy is not only minimally invasive, but also has fewer surgical complications, and the surgery can improve vision, perform pathological examination on the resected tissue, which is a safe and effective surgical method.